Onyx LES approved
This article was originally published in The Gray Sheet
Executive Summary
Micro Therapeutics, Inc., a subsidiary of ev3, launches Onyx LES liquid embolic system for treating brain arteriovenous malformations (AVMs) following long-awaited PMA approval, announced July 21. The firm expanded its salesforce to 15 U.S. reps at the end of 2004 in anticipation of an early 2005 approval. The system is indicated for the pre-surgical embolization of brain AVMs, which reduces the size and vascularity of the AVM, making it easier to surgically resection, the company explains (1"The Gray Sheet" Feb. 28, 2005, p. 24)...